SHARE

Farewell To 2023, And WE Are Sailing Forward To 2024 Farewell To 2023, And WE Are Sailing Forward To 2024
05.01.2024

Farewell To 2023, And WE Are Sailing Forward To 2024

Farewell To 2023, And WE Are Sailing Forward To 2024

Farewell to 2023, and WE are Sailing forward to 2024

Year-end Review for 2023

Throughout 2023, despite myriad challenges, Porton stood united, striving, and collaborating as one Team.

We are committed to developing our core CDMO business, continuously improve the EHS, Quality, and other support systems to lay a solid foundation for business development.

In May, Porton Chongqing Changshou Site and Shuitu R&D Center Passed the ISO9001, ISO14001, and ISO45001 Certifications.

Farewell To 2023, And WE Are Sailing Forward To 2024

In September, Porton Chongqing DP Site Passed the ISO14001 and ISO45001 Certifications.

Farewell To 2023, And WE Are Sailing Forward To 2024

In November, Porton Jiangxi Production Site Passed the U.S. FDA on-site Inspection.

Farewell To 2023, And WE Are Sailing Forward To 2024

Porton continuously advance the global layout, establish new capabilities, and better empower our customers.

In May, Porton New Shanghai R&D Facility was Opened for Operation.

Farewell To 2023, And WE Are Sailing Forward To 2024

In September, Porton Shanghai Antibody & ADC (Antibody-Drug Conjugate) R&D Center was Launched.

Farewell To 2023, And WE Are Sailing Forward To 2024

In September, the New Crystallization & Formulation R&D Facility of Porton USA was Opened for Operation.

Farewell To 2023, And WE Are Sailing Forward To 2024

Porton Continues to Push Forward with the Construction of the Slovenia GMP Manufacturing Site.

Farewell To 2023, And WE Are Sailing Forward To 2024

We maintain an open and collaborative attitude, continuously investing resources to promote brand building and create the Porton ecosystem.

In January, Porton Attended the J.P. Morgan Healthcare Conferences, Co-hold the Global CDMO Summit

Farewell To 2023, And WE Are Sailing Forward To 2024

In March, Porton Participated in DCAT Week, USA.

Farewell To 2023, And WE Are Sailing Forward To 2024

In June, Porton Advanced Organized The Third China Gene & Cell Therapy Innovation Forum(CGCT 2023)

Farewell To 2023, And WE Are Sailing Forward To 2024

In September, Porton Organized the Pharma Digital Intelligence Summit.



In October, Porton co-held the Fourth Pharma Crystallization Summit.



In October, Porton Attended 2023 CPHI Worldwide in Spain.



Strengthen the cooperation along the industrial supply chain and achieve win-win partnerships with industry peers.

In October, we joined hands with Merck to continuously carry out innovative collaborations in the field of antibodies and ADC (Antibody-Drug Conjugates).



In November, we established a strategic cooperation with YL-Pharma in the business of active pharmaceutical ingredients (APIs) and drug formulations.



In December, we reached a strategic cooperation with Fujian Cosunter Pharmaceutical Co, Ltd in the R&D as well as the supply chain of active pharmaceutical ingredients (APIs) and drug formulations.



Porton accelerates the enhancement of ESG management not only to improve our sustainable operating capabilities but also to create more environmental and social value.

  • In September, Porton Completed the Establishment of an ESG Governance and Management Framework.
  • In September, Porton Assessed and Identified 19 Materiality.

Porton Initiatives the "We Care" project of Tengyi charity activities, conveying our sincere and positive energy to society.

  • In April, the "Love for Farmers" activity;
  • In August, the "Build Dreams with Books" donation activity;
  • In August, the "Little Chemists" activity;
  • In November, the "Let Love Not Be Rare" DMD charity running activity.
  • And more…

Global recognition Spurs Porton to Continue Moving Forward.

  • Porton was awarded as a National-Level Intelligent Manufacturing Demonstration Factory.
  • Porton was honored as One of the Top 20 Chinese CXO Companies of 2022.
  • Porton was named as one of the Top Influential CDMO Companies of 2023.
  • Porton wins the 2023 Top Brands of Chinese Life Science Service Enterprise
  • Porton earned Outstanding Contribution Award by Shanghai YL-Pharma
  • Porton earned the Title of Best Partner of the Year 2023 by Xingsheng Xinhui.
  • Porton’s S&P Global ESG score rose to 38 points.
  • Porton elevated to the highest AAA level in the SZSE National Corporate ESG Rating.
  • Porton received the First Guoxin Cup ESG Golden Bull Award for Top 50 Technology Leaders.
  • Porton was awarded as an Outstanding Private Enterprise in Chongqing.
  • Porton was recognized among the Top 100 Private Enterprises in Chongqing Municipality.


SHARE

Farewell To 2023, And WE Are Sailing Forward To 2024 Farewell To 2023, And WE Are Sailing Forward To 2024
Porton Experts Invited To Participate In The University Of Perugia Master PRO-API Program, Aiding In The Training Of Green Process Chemistry Professionals Porton Will Be Participating In Biotech Outsourcing Strategies Events This June Proton At CPhI North America Again Porton 2023 ESG Report Upcoming Porton Shows In Europe And The USA:Shaping Our Future Together Porton Makes Debut At DCAT Week 2024 To Jointly Promote Industry Development Join Our Founder And CEO @ DCAT Week Porton Pharma Solutions Joined The SBTi To Drive Climate Action Farewell To 2023, And WE Are Sailing Forward To 2024 The Pharma Crystallization Summit (PCS) Is Held Annually To Bring Together Developers Of New Medicines With Crystallization Challenges And The Crystallization Experts (Solution Providers) In The Industry And Academia. Porton Gets Improved In The 2023 S&P Global ESG Score Porton Pharma Solutions Announces New Flagship Facility Offering Integrated API Crystallization And Drug Product Development Services Pharma Digital Intelligence Summit Will Be Held On 5th, September, 2023 [Important Notice] Porton Announcement Regarding The Change Of Email Domain Porton Unveils Its Small Molecule Platform Headquarters In Shanghai PORTON Starts Construction Of Its Facility For Antibodies And ADCs In Shanghai Porton At DCAT Week 2023: A Highly Successful And Strategic Event Porton Released 2022 CSR Report Porton Delivers Strong 2022 Performance With 127% Sales Growth Porton Gets Above-Average S&P Global Environmental, Social, And Governance (ESG) Score
News

Insights Unveiled: Delve into Our Global News Hub!

22.05.2024

Porton Pharma Solutions embark on the next frontier in Mengeš, Slovenia

  • Opening ceremony of the state-of-the-art research and development laboratories for active pharmaceutical ingredients, small molecules, of Porton in Mengeš

  • A donation of EUR 20,000.00 to the municipality of Mengeš for the restoration of a flooded kindergarten

  • New jobs and further growth in the field of API's small molecules in Slovenia, Mengeš

Read the news

Cookie settings

Your current status

Show details